Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Acivicin in 1985.

R H Earhart, G L Neil

    Advances in Enzyme Regulation
    |January 1, 1985
    PubMed
    Summary
    This summary is machine-generated.

    This review examines acivicin (a chemotherapy drug) development, exploring its optimal use, toxicity, and combination potential. Further research is needed to define its clinical utility against human tumors.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Docetaxel (Taxotere): preclinical and general clinical information.

    Seminars in oncology·1999
    Same author

    A phase II study of docetaxel in patients with paclitaxel-resistant metastatic breast cancer.

    Journal of clinical oncology : official journal of the American Society of Clinical Oncology·1998
    Same author

    Phase I study with the DNA sequence-specific agent adozelesin.

    Anti-cancer drugs·1997
    Same author

    Phase I trial of Adozelesin using the treatment schedule of daily x5 every 3 weeks.

    Investigational new drugs·1996
    Same author

    Evidence for paracrine regulation of experimental metastasis in 13762NF rat mammary adenocarcinoma cell clones.

    Anticancer research·1994
    Same author

    Phase I study of adozelesin administered by 24-hour continuous intravenous infusion.

    Journal of the National Cancer Institute·1994

    Area of Science:

    • Oncology
    • Pharmacology
    • Biochemistry

    Background:

    • Acivicin is an investigational chemotherapeutic agent.
    • Its development involves understanding its biochemical properties and potential applications.

    Purpose of the Study:

    • To review the current status of acivicin development.
    • To formulate hypotheses regarding optimal dosing, CNS toxicity, and combination chemotherapy.
    • To identify future research directions to overcome limitations.

    Main Methods:

    • Literature review of existing biochemical and preclinical data.
    • Analysis of current information gaps.
    • Projection of future research needs.

    Main Results:

    Related Experiment Videos

    • Hypotheses can be formulated regarding acivicin's regimen and toxicity.
    • Significant information deficits exist regarding its clinical activity spectrum.
    • Optimal use and toxicity management are crucial for defining its utility.

    Conclusions:

    • Acivicin's role in treating human malignancies requires further investigation.
    • Defining optimal regimens and addressing toxicities are essential next steps.
    • Coordinated preclinical and clinical efforts are necessary for acivicin's advancement.